England - East Anglia • Corporate and commercial

Taylor Wessing LLP

More informationMore information

Taylor Wessing LLP is noted as having ‘a strong corporate presence in the Cambridge ecosystem’. Practice co-heads are IP specialist Adrian Toutoungi and Ross McNaughton, who is regarded as ’a go-to adviser on venture capital transactions‘. The team counts numerous life sciences companies amongst its clients, including Shield Therapeutics plc, Cambridge Epigenetix and Fusion Antibodies. The firm recently acted for desktop bioprinting company Nuclera on its $58m series B financing.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Taylor Wessing has a strong corporate presence in the Cambridge ecosystem and frequently advise us and other market participants on transactional matters.’

  • ‘Ross McNaughton heads up the corporate team and is a go-to advisor in the market on venture capital transactions. He has strong full service support behind him and several able associates in his team.’

  • 'A great team with coordinated responses and fantastic communication, who are invested in clients' business.'

  • 'Ross McNaughton is pragmatic, business-focused and really cares about their clients. I cannot fault his service and advice.'

Key clients

  • Shield Therapeutics plc
  • Cambridge Epigenetix
  • IP Group plc
  • Apollo Therapeutics
  • Fusion Antibodies
  • Mitel Inc
  • Nyobolt
  • The Faraday Institution
  • Salience Labs
  • Start Codon
  • Abbott
  • Pacira Biosciences
  • Nuclera
  • New Science Ventures
  • PLACID0
  • Five.AI
  • Oxford Science Enterprises PLC
  • 2150 Urban Tech Sustainability Fund

Work highlights

  • Advised bioprinting pioneer Nuclera on its $58m series B financing.
  • Advised leading US deep-tech investor New Science Ventures, on the $60m Series B venture financing it led on for Paragraf.
  • Advising Cambridge Epigenetix (CEGX) in relation to its various corporate matters and collaborations with among others, Guardant, Freenome, Agilent and Roche.

Lawyers

Practice head

The lawyer(s) leading their teams.

Ross McNaughton, Adrian Toutoungi